Literature DB >> 24578477

Risk of stillbirth and infant deaths after assisted reproductive technology: a Nordic study from the CoNARTaS group.

A A Henningsen1, U B Wennerholm, M Gissler, L B Romundstad, K G Nygren, A Tiitinen, R Skjaerven, A Nyboe Andersen, Ø Lidegaard, J L Forman, A Pinborg.   

Abstract

STUDY QUESTION: Is the risk of stillbirth and perinatal deaths increased after assisted reproductive technology (ART) compared with pregnancies established by spontaneous conception (SC)? SUMMARY ANSWER: A significantly increased risk of stillbirth in ART singletons was only observed before 28 + 0 gestational weeks. WHAT IS KNOWN ALREADY: The current literature indicates that children born after ART have an increased risk of perinatal death. The knowledge on stillbirth in ART pregnancies is limited. STUDY DESIGN, SIZE, DURATION: A population based case-control study. PARTICIPANTS/MATERIALS, SETTING AND METHODS: A total of 62 485 singletons and 29 793 twins born after ART in Denmark, Finland, Norway and Sweden, from 1982 to 2007, were compared with 362 798 spontaneously conceived (SC) singletons and 132 181 twins. MAIN RESULTS AND THE ROLE OF CHANCE: The adjusted rate ratio for stillbirth at gestational weeks 22 + 0 to 27 + 6 was 2.08 [95% confidence interval (CI) 1.55-2.78] for ART versus SC singletons. After 28 + 0 gestational weeks there was no significant difference in the risk of stillbirth between ART and SC singletons. ART twins had a lower risk of stillbirth compared with SC twins, but when restricting the analysis to opposite-sex twins and excluding all monozygotic twins, there was no significant difference between the groups. Singletons conceived by ART had an overall increased risk of early neonatal death (adjusted odds ratio 1.54, 95% CI 1.28-1.85) and death within the first year after birth (1.45, 1.26-1.68). No difference regarding these two parameters was found when further adjusting for the gestational age [(0.97, 0.80-1.18) and (0.99, 0.85-1.16), respectively]. ART twins had a lower risk of early neonatal and infant deaths than SC twins, but no difference was found when restricting the analyses to opposite-sex twins. LIMITATIONS, REASON FOR CAUTION: We were not able to adjust for potential confounders, such as a prior history of stillbirth, induction of labour, body mass index or smoking. WIDER IMPLICATIONS OF THE
FINDINGS: The risk of stillbirth in ART versus SC singletons was only increased for very early gestational ages (before 28 weeks). This might indicate that the current clinical management of ART pregnancies is sufficient regarding prevention of stillbirth during the third trimester. STUDY FUNDING/COMPETING INTEREST(S): No conflict of interest was reported. The European Society for Human Reproduction and Embryology (ESHRE), the University of Copenhagen, Denmark, the Danish Agency for Science, Technology and Innovation and Sahlgrenska University Hospital, Gothenburg, Sweden supported the project. The CoNARTaS group has received travel and meeting funding from the Nordic Society of Obstetrics and Gynecology (NFOG).

Entities:  

Keywords:  assisted reproductive technology; infant death; preterm birth; small-for-gestational age; stillbirth

Mesh:

Year:  2014        PMID: 24578477     DOI: 10.1093/humrep/deu031

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  9 in total

1.  The cumulative effect of assisted reproduction procedures on placental development and epigenetic perturbations in a mouse model.

Authors:  Eric de Waal; Lisa A Vrooman; Erin Fischer; Teri Ord; Monica A Mainigi; Christos Coutifaris; Richard M Schultz; Marisa S Bartolomei
Journal:  Hum Mol Genet       Date:  2015-09-23       Impact factor: 6.150

2.  Risk of Preeclampsia in Pregnancies After Assisted Reproductive Technology and Ovarian Stimulation.

Authors:  Angela S Martin; Michael Monsour; Jennifer F Kawwass; Sheree L Boulet; Dmitry M Kissin; Denise J Jamieson
Journal:  Matern Child Health J       Date:  2016-10

3.  Defining critical factors in multi-country studies of assisted reproductive technologies (ART): data from the US and UK health systems.

Authors:  Michael L Eisenberg; Barbara Luke; Katherine Cameron; Gary M Shaw; Allan A Pacey; Alastair G Sutcliffe; Carrie Williams; Julian Gardiner; Richard A Anderson; Valerie L Baker
Journal:  J Assist Reprod Genet       Date:  2020-09-30       Impact factor: 3.412

4.  Multiple birth rates of Korea and fetal/neonatal/infant mortality in multiple gestation.

Authors:  Hyun Sun Ko; Jeong Ha Wie; Sae Kyung Choi; In Yang Park; Yong-Gyu Park; Jong Chul Shin
Journal:  PLoS One       Date:  2018-08-15       Impact factor: 3.240

Review 5.  Perinatal outcome in children born after assisted reproductive technologies.

Authors:  Ulla-Britt Wennerholm; Christina Bergh
Journal:  Ups J Med Sci       Date:  2020-03-03       Impact factor: 2.384

6.  Effects of donor sperm on perinatal and neonatal outcomes resulting from in vitro fertilization-intracytoplasmic sperm injection and embryo transfer cycles: a retrospective cohort study.

Authors:  Xinyan Gao; Shihu Sun; Lei Xie; Shaoming Lu
Journal:  Ann Transl Med       Date:  2022-08

7.  The data we have: Pregnancy and birth related data collection in Australia, Canada, Europe and the USA - A web-based survey of practice.

Authors:  K Lamont; N W Scott; S Bhattacharya
Journal:  Int J Popul Data Sci       Date:  2021-03-22

Review 8.  Risks of spontaneously and IVF-conceived singleton and twin pregnancies differ, requiring reassessment of statistical premises favoring elective single embryo transfer (eSET).

Authors:  Norbert Gleicher; Vitally A Kushnir; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2016-05-03       Impact factor: 5.211

9.  Pregnancy and neonatal outcomes in fresh and frozen cycles using blastocysts derived from ovarian stimulation with follitropin delta.

Authors:  Jon Havelock; Anna-Karina Aaris Henningsen; Bernadette Mannaerts; Joan-Carles Arce
Journal:  J Assist Reprod Genet       Date:  2021-07-13       Impact factor: 3.412

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.